Article Information
History
- December 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kaori Sano1,
- Disha Bhavsar1,
- Gagandeep Singh1,
- Daniel Floda1,
- Komal Srivastava1,
- Charles Gleason1,
- PARIS Study Group1,
- Juan Manuel Carreño1,
- Viviana Simon1,2,3,4 and
- Florian Krammer1,2,*
- 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 2Department of Pathology, Molecular and Cell Based Medicine Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 3Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 4The Global Health and Emerging Pathogen Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*To whom correspondence should be addressed: florian.krammer{at}mssm.edu
Posted December 11, 2021.
Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals
